asco 2023 - astrazeneca - positive results from adaura phase iii trial
Published 1 year ago • 197 plays • Length 11:58Download video MP4
Download video MP3
Similar videos
-
6:20
asco 2023 highlights on adjuvant osimertinib in resected egfr mutated nsclc: the adaura trial
-
4:47
asco 2023 expert report on novelties in oncogene driven nsclc by a. curioni-fontecedro
-
47:21
asco 2023: highlights and analysis
-
3:30
asco 2023: top research & trial updates
-
6:33
asco daily news 2023 plenary update - lba3: adaura
-
7:15
asco 2023 expert report in hr positive, her2 negative breast cancer by catherine harper-wynne
-
11:30
asco guideline highlights for the treatment of metastatic colorectal cancer
-
12:14
asco 2024 - scot ebbinghaus
-
11:41
the adaura trial: flaws and results - leading developments & current questions in lung cancer
-
0:55
lung cancer at asco 2023: adaura and adcs
-
4:47
asco 2023 highlights on erdafitinib in metastatic urothelial cancer with select fgfr alterations
-
1:31
asco 2023: highlights in non-small cell lung cancer
-
0:20
lung cancer trial updates at asco 2023
-
11:20
the oncology brothers discuss adaura trial findings
-
11:37
asco23 - lba3: os analysis from the adaura trial of adjuvant osimertinib in resected egfr‐mutate...
-
1:40
highlights in lung cancer from asco 2024
-
3:16
adaura phase iii trial data: practice changing?
-
2:56
dr. patrick forde discusses 3-year checkmate 816 nsclc results at asco 2023
-
0:39
highlights at asco 2023